PATENT CLAIM ANALYSIS

Application Number: 16057701
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "401000"]

Abstract:
Described herein are compounds for and methods of treating conditions or diseases in a subject by administering to the subject a pharmaceutical composition containing an effective amount of an α-adrenergic modulator. The compounds and methods are also useful for alleviating types of pain, acute, neuropathic and chronic.

Claim (Index 3):
The method of  claim 1 , wherein the dose is administered by an oral route.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.34211
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14692042', '12479129', '13275029', '15446650', '10031037']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7747190935368552
- 35 USC 102 Novelty (BERT): 0.5389232118555443
- Combined Prediction Score: 0.7511395053687241
- Mean Citation Score: 328.49072
- Max Citation Score: 363.30563
- Similarity Product: 349.67628984676963

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test